Skip to main content
graph.swiss
Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc.

74.50 CHF+1.00 (+1.36%)
XSWX:ZBHMarket Closed
ListedCHF14.4BHealthcareMedical Devices17,000 employees

Company Profile

Legal NameZimmer Biomet Holdings, Inc.
CEOMr. Ivan Tornos
Headquarters345 East Main Street
Phone574 373 3333
Employees (FTE)17,000
SectorHealthcare
IndustryMedical Devices

Business Description

Zimmer Biomet Holdings, Inc. is a medical device company specializing in musculoskeletal healthcare solutions. The company designs, manufactures, and markets orthopedic reconstructive implants for hips, knees, and shoulders, along with a broad range of products for sports medicine, extremities, and trauma surgery. Its portfolio also includes surgical tools, biologics, and digital and robotic technologies that support orthopedic procedures and post-operative care. Zimmer Biomet serves hospitals, ambulatory surgery centers, and healthcare professionals worldwide, focusing on products that enable joint replacement, bone repair, and improved mobility for patients. Following the spin-off of its dental and spine businesses, the company is concentrated on large joint reconstruction and related musculoskeletal products as core areas of activity. Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet holds a significant position in the global orthopedic market, particularly in the United States, Europe, and Japan, where it is a key supplier to orthopedic surgeons and healthcare systems.

Profitability & Growth

Profitability

Profit Margin+9.05%
Operating Margin+19.69%
Return on Equity (TTM)+6.07%
Return on Assets (TTM)+4.10%

Recent Year-End

Revenue6.81B
Revenue / Share42.68
Gross Profit4.78B
EBITDA2.54B
Diluted EPS2.98
Earnings Growth YoY+30.80%
Revenue Growth YoY+9.30%

Balance Sheet Snapshot

Total Cash (MRQ)

387.3M

Total Debt (MRQ)

6.14B

Current Ratio (MRQ)

1.73

Book Value / Share

53.02

Stock Statistics

Shares Outstanding193.4M
Float Shares192.9M
Avg Volume (10d)0
Avg Volume (90d)0
% Held by Insiders+0.15%
% Held by Institutions+106.37%

Valuation

Market Cap14.41B
Enterprise Value17.27B
Trailing P/E20.97
PEG Ratio0.64
Price / Sales (TTM)1.44
Price / Book (MRQ)1.18
EV / Revenue2.54
EV / EBITDA8.27

Price Summary

52-Week Low62.50
52-Week High119.00
50-Day MA68.71
200-Day MA73.68
Beta0.46

Dividends

Forward Div Rate0.77
Forward Div Yield+1.04%
Trailing Div Rate0.77
5Y Avg Div Yield+85.00%
Payout Ratio+24.87%
Dividend Date2025-04-30
Ex-Dividend Date2026-06-25